Pharmacotherapy of aphasia: A critical review

Stroke

Volumn 25, Issue 6, 1994, Pages 1282-1289

  Small, Steven L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aphasia; Language; Pharmacology

Indexed keywords

AMPHETAMINE; CATECHOLAMINE; DOPAMINE; HALOPERIDOL; NORADRENALIN; PROPRANOLOL DERIVATIVE;

APHASIA; CEREBROVASCULAR DISEASE; COMMUNICATION DISORDER; DOPAMINE RELEASE; DRUG USE; HUMAN; LANGUAGE; NORADRENALIN RELEASE; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR FUNCTION; STROKE;

ANIMAL; APHASIA; BRAIN CHEMISTRY; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROVASCULAR DISORDERS; HUMAN; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028229194     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.25.6.1282     Document Type: Review

References (65)

1. Robinson MK, Toole JF. Ischemic cerebrovascular disease. In: Joynt R, ed. Clinical Neurology. Philadelphia, Pa: JB Lippincott Co; 1989:chap 10.
2. Benson DF, Geschwind N. The aphasias and related disturbances. In: Joynt R, ed. Clinical Neurology. Philadelphia, Pa: JB Lippincott Co; 1989:chap 15.
3. Swindell CS, Boiler F, Holland AL. Expressive language in probable Alzheimer's disease. Aphasiology. 1988;2:411-416.
4. Cooper JA, ed. Aphasia Treatment: Current Approaches and Research Opportunities. Bethesda, Md: National Institutes of Health, US Public Health Service; 1992:152.
5. Byng S. Sentence processing deficits: theory and therapy. Cog Neuropsych. 1988;5:629-676.
6. Mitchum C, Berndt R. An Intervention Strategy to Improve Sentence Production in Aphasia. Presented at the Twenty-Eighth Annual Meeting of the Academy of Aphasia. Baltimore, Md, 1990.
7. Fromm D, Holland AL. Functional communication in Alzheimer's disease. J Speech Hear Dis. 1989;54:535-540.
8. Duffy JR. Schuell's stimulation approach to rehabilitation. In: Chapey R, ed. Language Intervention Strategies in Adult Aphasia. Baltimore, Md: Williams & Wilkins; 1985:187-214.
9. Cooper JR, Bloom FE, Roth RH. The Neuropharmacological Basis of Behavior. New York, NY: Oxford University Press; 1991.
10. Johnston MV, MacDonald R, Young A, eds. Principles of Drug Therapy in Neurology. Philadelphia, Pa: FA Davis; 1992.
11. Johnston MV. Cognitive disorders. In: Johnston MV, MacDonald R, Young A, eds. Principles of Drug Therapy in Neurology. Philadelphia, Pa: FA Davis; 1992.
12. Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med. 1992;327:1253-1259.
13. Colton CA, Gilbert DL, Nelson RB. The formation of β-amyloid plaque component aggregates under oxidizing conditions. Proceedings of the Annual Meeting of the Society for Neuroscience. 1993;1:184. Abstract.
14. Gilman AG, Goodman LS, Rall TW, Murad F. The Pharmacological Basis of Therapeutics. 7th ed. New York, NY: MacMillan Publishing Co, 1985.
15. Cohen HP, Woltz AG, Jacobson RL. Catecholamine content of cerebral tissue after occlusion or manipulation of middle cerebral artery in cats. J Neurosurg. 1975;43:32-36.
16. Brown RM, Carlson A, Ljungren BL, Seisjo BK, Snider SR. Effect of ischemia on monoamine metabolism in the brain. Acta Scand Physiol. 1974;90:789-791.
17. Robinson RG, Shoemaker WJ, Schlumpf M. Time course of changes in catecholamines following right hemisphere cerebral infarction in the rat. Brain Res. 1980;181:202-208.
18. Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. Effect of experimental cerebral infarction in rat brain on catecholamines and behavior. Nature. 1975;255:332-334.
19. Robinson RG. Differential behavioral and biochemical effects of right and left hemisphere cerebral infarction in the rat. Science. 1979;205:707-710.
20. Feeney DM, Sutton RL, Boyeson MG, Hovda DA, Dail WG. The locus ceruleus and cerebral metabolism: recovery of function after cortical injury. Physiol Psychol. 1985;13:197-203.
21. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982;217:855-857.
22. Goldstein LB, Miller GD, Cress NM, Tyson AG, Davis JN. Studies of an animal model for the recovery of function after stroke. Ann Neurol. 1988;22:159-160. Abstract.
23. Boyeson MG, Feeney DM. The role of norepinephrine in recovery from brain injury. Proceedings of the Annual Meeting of the Society for Neuroscience. 1984:68. Abstract.
24. Feeney DM, Hovda DA. Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. Psychopharmacology (Berl). 1983;79:67-71.
25. Hovda DA, Feeney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res. 1984;298:358-361.
26. Feeney DM, Hovda DA. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res. 1985;342:352-356.
27. Caramazza A. On drawing inferences about the structure of normal cognitive systems from the analysis of patterns of impaired performance: the case for single-patient studies. Brain Cog. 1986; 5:41-66.
28. Damasio H, Damasio AR. Lesion Analysis in Neuropsychology. New York, NY: Oxford University Press; 1989:227.
29. Petersen SE, Fox PT, Posner MI, Mintun MA, Raichle ME. Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature. 1988;331:585-589.
30. McCarthy G, Blamire AM, Rothman DL, Gruetter R, Shulman RG. Echo-planar magnetic resonance imaging studies of frontal cortex activation during word generation in humans. Proc Natl Acad Sci U S A. 1993;90:4952-4956.
31. Porch B, Wyckes J, Feeney DM. Haloperidol, thiazides, and some antihypertensives slow recovery from aphasia. Proceedings of the Annual Meeting of the Society for Neuroscience. 1985:52. Abstract.
32. Porch BE. Porch Index of Communicative Ability, I: Theory and Development. Palo Alto, California: Consulting Psychologists Press, 1967.
33. Fisher CM, Curry HB. Pure motor hemiplegia of vascular origin. Arch Neurol. 1965;13:30-44.
34. Linn L. Sodium amytal in treatment of aphasia. Arch Neurol Psychiatry. 1947;58:357-358.
35. Wells CR, Labar DR, Solomon GE. Aphasia as the sole manifestation of simple partial status epilepticus. Epilepsia. 1992;33:84-87.
36. Lesser RP. Aphasia as the initial manifestation of epilepsy. Mayo Clin Proc. 1991;66:325-326.
37. Rosenbaum DH, Siegel M, Barr WB, Rowan AJ. Epileptic aphasia. Neurology. 1986;36:822-825.
38. Bergman PS, Green M. Aphasia: effect of intravenous sodium amytal. Neurology. 1951;1:471-475.
39. West R, Stockel S. The effect of meprobamate on recovery from aphasia. J Speech Hear Res. 1965;8:57-62.
40. Sarno MT, Sarno JE, Diller L. The effect of hyperbaric oxygen on communication function in adults with aphasia secondary to stroke. J Speech Hear Res. 1972;15:42-48.
41. Meyer JS, Stoica E, Pascu I, Shimazu K, Hartman A. Catecholamine concentrations in CSF and plasma of patients with cerebral infarction and haemorrhage. Brain. 1973;96:277-288.
42. Albert ML, Bachman DL, Morgan A, Helm-Estabrooks N. Pharmacotherapy for aphasia. Neurology. 1988;38:877-879.
43. Albert ML. Aphasia is now treatable. Hosp Prac. 1988;23:31-38.
44. MacLennan DL, Nicholas LE, Morley GK, Brookshire RH. The effects of bromocriptine on speech and language function in a man with transcortical motor aphasia. Clin Aphasiol. 1991;21:145-155.
45. Gupta SR, Micoch AG. Bromocriptine treatment of nonfluent aphasia. Arch Phys Med Rehab. 1992;73:373-376.
46. Sabe L, Leiguarda R, Starkstein SE. An open-label trial of bromocriptine in nonfluent aphasia. Neurology. 1992;42:1637-1638.
47. Clark ANG, Mankikar GD. d-Amphetaminc in elderly patients refractory to rehabilitation procedures. J Am Geriatr Soc. 1979;27: 174-177.
48. Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol. 1988; 23:94-97.
49. Darley FL, Keith RL, Sasanuma S. The effect of alerting and tranquilizing drugs upon the performance of aphasic patients. Clin Aphasiol. 1977;7:91-96.
50. Walker-Batson D, Devous MD, Curtis S, Unwin DH, Greenlee RG. Response to amphetamine to facilitate recovery from aphasia subsequent to stroke. Clin Aphasiol. 1991;21:137-143.
51. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of post-stroke mood disorders. Brain. 1987;110:1045-1059.
52. Starkstein SE, Robinson RG, Berthier ML, Parikh RM, Price TR. Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol. 1988;45:725-730.
53. Benson DF. Psychiatric aspects of aphasia. Br J Psychia'ry. 1973; 123:555-566.
54. Stern RA, Bachman DL. Depressive symptoms following stroke. Am J Psychiatry. 1991;148:351-356.
55. Raven JC. Guide to Using the Coloured Progressive Matrices. London, England: Lewis; 1965.
56. Wechsler D. Wechsler Adult Intelligence Scale - Revised. New York, NY: The Psychological Corporation; 1981.
57. De Renzi E, Vignolo LA. The Token test: a sensitive test to detect receptive disturbance in aphasics. Brain. 1962;85:665-678.
58. Taylor ML. A measurement of functional communication in aphasia. Arch Phys Med Rehabil. 1965;46:101-107.
59. Sarno MT. The Functional Communication Profile: Manual of Directions. Technical Report Rehabilitation Monograph 42. New York, NY: New York University Medical Center; 1969.
60. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia. 1967;5:135-140.
61. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. Philadelphia, Pa: Lea & Febiger; 1972.
62. Kaplan E, Goodglass J, Weintraub S. Boston Naming Test. Philadelphia, Pa: Lea & Febiger; 1983.
63. Kertesz A. The Western Aphasia Battery. New York, NY: Grune & Stratton Inc; 1982.
64. Walker-Batson D, Unwin H, Curtis S, Allen E, Wood M, Smith P, Devous MD, Reynolds S, Greenlee RG. Use of amphetamine in the treatment of aphasia. Restor Neurol Neurosci. 1992;4:47-50.
65. Benson DF. Presentation 10. In: Benton AL, ed. Behavioral Change in Cerebrovascular Disease. New York, NY: Harper and Row; 1970:77.